Boehringer Ingelheim Pharmaceuticals
Boehringer Ingelheim Pharmaceuticals, Inc.
900 Ridgebury Road
Ridgefield, CT 06877
Phone: (800) 243-0127Website: https://www.boehringer-ingelheim.us/Careers: www.boehringer-ingelheim.us/careersPatient Assistance Program: www.boehringer-ingelheim.us...
Latest news
- US FDA Approves High-Concentration, Citrate-Free Formulation of Cyltezo (adalimumab-adbm) injection
2 May 2024 - FDA Approves Expanded Generalized Pustular Psoriasis Indications for Spevigo
19 March 2024 - US FDA Approves Jardiance for the Treatment of Adults with Chronic Kidney Disease
22 September 2023 - FDA Approves Jardiance (empagliflozin) for the Treatment of Type 2 Diabetes in Children 10 Years and Older
21 June 2023 - US FDA Approves the Cyltezo Pen, a New Autoinjector Option, Ahead of July 1 Commercial Launch
22 May 2023 - EMPA-KIDNEY trial showed significant benefit of Jardiance in reducing kidney disease progression or cardiovascular death in people with chronic kidney disease
4 November 2022 - FDA Approves Spevigo (spesolimab-sbzo) for Generalized Pustular Psoriasis (GPP) Flares in Adults
3 September 2022 - New Spesolimab Data Showed Significant Improvement in Patients with Generalized Pustular Psoriasis (GPP) Flares
28 March 2022 - US FDA Approves Jardiance (empagliflozin) to Treat Adults with Heart Failure Regardless of Left Ventricular Ejection Fraction
25 February 2022 - Newly Published Results Showed Spesolimab Significantly Improved Signs and Symptoms of Flares in Rare, Life-Threatening Skin Disease, Generalized Pustular Psoriasis
23 December 2021
Drugs Associated with Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 36 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Aggrenox
Generic name: aspirin/dipyridamole Drug class: platelet aggregation inhibitors |
17 reviews | 7.1 / 10 |
|
Aptivus
Generic name: tipranavir Drug class: protease inhibitors |
||
|
Atrovent HFA
Generic name: ipratropium Drug class: anticholinergic bronchodilators |
3 reviews | 8.7 / 10 |
|
Atrovent Nasal
Generic name: ipratropium Drug class: nasal antihistamines and decongestants |
3 reviews | 10 / 10 |
|
Basaglar
Generic name: insulin glargine Drug class: insulin |
130 reviews | 2.6 / 10 |
|
Catapres
Generic name: clonidine Drug class: antiadrenergic agents, centrally acting |
47 reviews | 7.9 / 10 |
|
Catapres-TTS
Generic name: clonidine Drug class: antiadrenergic agents, centrally acting |
10 reviews | 8.1 / 10 |
|
Combivent Respimat
Generic name: albuterol/ipratropium Drug class: bronchodilator combinations |
17 reviews | 3.9 / 10 |
|
Cyltezo
Generic name: adalimumab Drug class: TNF alfa inhibitors |
||
|
Duo Fusion
Generic name: calcium carbonate/famotidine/magnesium hydroxide Drug class: H2 antagonists |
||
|
Flomax
Generic name: tamsulosin Drug class: alpha blockers |
276 reviews | 5.9 / 10 |
|
Gilotrif
Generic name: afatinib Drug class: multikinase inhibitors |
1 review | 10 / 10 |
|
Glyxambi
Generic name: empagliflozin/linagliptin Drug class: antidiabetic combinations |
20 reviews | 6.5 / 10 |
|
Jardiance
Generic name: empagliflozin Drug class: SGLT-2 inhibitors |
302 reviews | 5.3 / 10 |
|
Jentadueto
Generic name: linagliptin/metformin Drug class: antidiabetic combinations |
13 reviews | 5.8 / 10 |
|
Jentadueto XR
Generic name: linagliptin/metformin Drug class: antidiabetic combinations |
2 reviews | 9.0 / 10 |
|
Micardis
Generic name: telmisartan Drug class: angiotensin receptor blockers |
38 reviews | 6.0 / 10 |
|
Micardis HCT
Generic name: hydrochlorothiazide/telmisartan Drug class: angiotensin II inhibitors with thiazides |
13 reviews | 7.1 / 10 |
|
Mirapex ER
Generic name: pramipexole Drug class: dopaminergic antiparkinsonism agents |
7 reviews | 8.9 / 10 |
|
Mobic
Generic name: meloxicam Drug class: Nonsteroidal anti-inflammatory drugs |
124 reviews | 7.5 / 10 |
|
Ofev
Generic name: nintedanib Drug class: multikinase inhibitors |
23 reviews | 8.0 / 10 |
|
Persantine
Generic name: dipyridamole Drug class: cardiac stressing agents, platelet aggregation inhibitors |
||
|
Pradaxa
Generic name: dabigatran Drug class: thrombin inhibitors |
91 reviews | 7.1 / 10 |
|
Praxbind
Generic name: idarucizumab Drug class: anticoagulant reversal agents |
||
|
Spevigo
Generic name: spesolimab Drug class: interleukin inhibitors |
||
|
Spiriva
Generic name: tiotropium Drug class: anticholinergic bronchodilators |
108 reviews | 5.8 / 10 |
|
Spiriva Respimat
Generic name: tiotropium Drug class: anticholinergic bronchodilators |
30 reviews | 5.4 / 10 |
|
Stiolto Respimat
Generic name: olodaterol/tiotropium Drug class: bronchodilator combinations |
45 reviews | 7.2 / 10 |
|
Striverdi Respimat
Generic name: olodaterol Drug class: adrenergic bronchodilators |
5 reviews | 4.6 / 10 |
|
Synjardy
Generic name: empagliflozin/metformin Drug class: antidiabetic combinations |
23 reviews | 6.4 / 10 |
|
Synjardy XR
Generic name: empagliflozin/metformin Drug class: antidiabetic combinations |
11 reviews | 4.9 / 10 |
|
Tradjenta
Generic name: linagliptin Drug class: dipeptidyl peptidase 4 inhibitors |
67 reviews | 3.3 / 10 |
|
Trijardy XR
Generic name: empagliflozin/linagliptin/metformin Drug class: antidiabetic combinations |
||
|
Twynsta
Generic name: amlodipine/telmisartan Drug class: angiotensin II inhibitors with calcium channel blockers |
12 reviews | 8.3 / 10 |
|
Viramune
Generic name: nevirapine Drug class: NNRTIs |
2 reviews | 4.5 / 10 |
|
Viramune XR
Generic name: nevirapine Drug class: NNRTIs |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
Discontinued Drugs
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Mirapex
Generic name: pramipexole Drug class: dopaminergic antiparkinsonism agents |
116 reviews | 7.2 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||